US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: Unveiling a 26.3% Potential Upside with Strong Revenue Growth

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust product pipeline and impressive revenue growth...

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 43.24% Potential Upside for Healthcare Investors

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is making waves in the healthcare sector with a significant potential upside of 43.24%, drawing considerable interest from investors. With a..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 244.69% Potential Upside in Revolutionary CAR-T Therapies

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, has been making waves with its innovative approach to cell therapy. Headquartered in Somerset,..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 14.75% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) is a prominent player in the healthcare sector, specifically within the healthcare plans industry. With a robust market capitalization of $3.99..

Waters Corporation (WAT) Stock Analysis: Key Insights on Potential 24.54% Upside for Investors

Waters Corporation (NYSE: WAT), a leading player in the Healthcare sector, particularly within the Diagnostics & Research industry, is making waves in the investment community with..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring the 21.96% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, specializes in the development and commercialization of innovative diagnostic and therapeutic products. With a..

Labcorp Holdings Inc. (LH) Investor Outlook: Analyzing the 6.21% Potential Upside

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating 11.20% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Koninklijke Philips N.V. (PHG) presents an intriguing proposition. With a market capitalization of $29.96 billion, this Netherlands-based medical..

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: Analyzing a 13.06% Potential Upside

Ionis Pharmaceuticals, Inc. (IONS), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust pipeline of RNA-targeted medicines and a..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Biotech Firm Surges with 200% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company focused on developing therapeutics for rare diseases, is capturing investor attention with a remarkable potential upside of..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 77% Potential Upside in the Healthcare Sector

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare industry, specializing in providing cloud-based solutions for the life sciences sector. With a..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) stands at the forefront of innovation in the biotechnology sector, leveraging its cutting-edge AOC (antibody oligonucleotide conjugates) platform. This San Diego-based..

Prestige Consumer Healthcare (PBH) Investor Outlook: A 16.53% Potential Upside Amid Robust Analyst Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH) is making waves in the healthcare sector with a compelling growth narrative that should catch the eye of savvy investors...

Viatris Inc. (VTRS) Stock Analysis: Healthcare Powerhouse with a 3% Dividend Yield Amidst Mixed Ratings

Viatris Inc. (NASDAQ: VTRS), a significant player in the healthcare sector, is drawing attention from investors with its expansive global footprint and a market capitalization of..

Sarepta Therapeutics (SRPT) Investor Outlook: Exploring the 20.49% Potential Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a pivotal player in the biotechnology sector, is capturing attention with a potential upside of 20.49%, according to recent analyst ratings...

Bausch + Lomb (BLCO) Stock Analysis: Eyeing Growth with a 7.1% Revenue Boost and Strategic Market Presence

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the healthcare sector, has captured investor attention with its solid revenue growth and expansive global operations...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Exploring a 14.59% Upside Potential

Medpace Holdings, Inc. (NASDAQ: MEDP) has captured the attention of investors with its impressive growth metrics and a potential upside of 14.59%, making it a compelling..

Corcept Therapeutics (CORT) Stock Analysis: Unlocking a Potential 110% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a compelling entity within the biotechnology sector, engaging in the development of therapies for severe endocrinologic, oncologic, metabolic, and neurologic..

Merit Medical Systems (MMSI): Investor Outlook Reveals 27.69% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading player in the medical instruments and supplies industry, offers investors an intriguing proposition with a significant potential upside..

Centene Corporation (CNC) Stock Report: Navigating Healthcare with a 23.10% Revenue Growth Boost

Centene Corporation (CNC), a formidable player in the healthcare sector, particularly within the healthcare plans industry, has been capturing investor attention with its robust revenue growth..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds